Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
«Do Not Do» recommendations for retinopathies: A mixed consensus study.
Pablo L, Beckford CA, Martin-Delgado J, Ferro Osuna M, Fernández-Ferreiro A, Fernández Rodriguez MI, Rodríguez Cid MJ, Méndez S, Torres A, Ignacio E, Mira JJ. Pablo L, et al. Among authors: fernandez rodriguez mi. Arch Soc Esp Oftalmol (Engl Ed). 2021 Feb 18:S0365-6691(21)00034-4. doi: 10.1016/j.oftal.2021.01.007. Online ahead of print. Arch Soc Esp Oftalmol (Engl Ed). 2021. PMID: 33612365 English, Spanish.
[Kearns-Sayre syndrome: ophthalmic manifestations].
Bande Rodriguez M, Pose Bazarra S, Treus Suarez A, Abraldes Lopez-Veiga M, Fernandez Rodriguez MI, Rodriguez Cid MJ. Bande Rodriguez M, et al. Among authors: fernandez rodriguez mi. An Pediatr (Barc). 2015 Jan;82(1):e151-3. doi: 10.1016/j.anpedi.2014.05.012. Epub 2014 Nov 20. An Pediatr (Barc). 2015. PMID: 25441208 Free article. Spanish.
Pharmacological Advances in the Treatment of Age-related Macular Degeneration.
Gil-Martínez M, Santos-Ramos P, Fernández-Rodríguez M, Abraldes MJ, Rodríguez-Cid MJ, Santiago-Varela M, Fernández-Ferreiro A, Gómez-Ulla F. Gil-Martínez M, et al. Curr Med Chem. 2020;27(4):583-598. doi: 10.2174/0929867326666190726121711. Curr Med Chem. 2020. PMID: 31362645 Review.
«Do Not Do» recommendations for retinopathies: A mixed consensus study.
Pablo L, Beckford CA, Martin-Delgado J, Ferro Osuna M, Fernández-Ferreiro A, Fernández Rodriguez MI, Rodriguez Cid MJ, Méndez S, Torres A, Ignacio E, Mira JJ. Pablo L, et al. Among authors: fernandez rodriguez mi. Arch Soc Esp Oftalmol (Engl Ed). 2021 Nov;96(11):578-586. doi: 10.1016/j.oftale.2021.01.007. Epub 2021 Oct 17. Arch Soc Esp Oftalmol (Engl Ed). 2021. PMID: 34756279 Review.
Influence of Genetic Polymorphisms on the Short-Term Response to Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration.
García-Quintanilla L, Almuiña-Varela P, Maroñas O, Gil-Rodriguez A, Rodríguez-Cid MJ, Gil-Martinez M, Abraldes MJ, Gómez-Ulla de Irazazabal F, González-Barcia M, Mondelo-Garcia C, Cruz R, Estany-Gestal A, Fernández-Rodríguez M, Fernández-Ferreiro A. García-Quintanilla L, et al. Invest Ophthalmol Vis Sci. 2023 Oct 3;64(13):34. doi: 10.1167/iovs.64.13.34. Invest Ophthalmol Vis Sci. 2023. PMID: 37862026 Free PMC article.
The Effect of Systemic Parameters and Baseline Characteristics in Short-Term Response Analysis with Intravitreal Ranibizumab in Treatment-Naive Patients with Neovascular Age-Related Macular Degeneration.
García-Quintanilla L, Almuiña-Varela P, Rodríguez-Cid MJ, Gil-Martínez M, Abraldes MJ, Gómez-Ulla F, González-Barcia M, Mondelo-García C, Estany-Gestal A, Otero-Espinar FJ, Fernández-Rodríguez M, Fernández-Ferreiro A. García-Quintanilla L, et al. Pharmaceutics. 2024 Jan 13;16(1):105. doi: 10.3390/pharmaceutics16010105. Pharmaceutics. 2024. PMID: 38258115 Free PMC article.
Relationships between Patient-Reported Outcome Measures and Clinical Measures in Naïve Neovascular Age-Related Macular Degeneration Patients Treated with Intravitreal Ranibizumab.
Almuiña-Varela P, García-Quintanilla L, Rodríguez-Cid MJ, Gil-Martínez M, Abraldes MJ, Gómez-Ulla F, Estany-Gestal A, Alcántara-Espinosa JM, Fernández-Rodríguez M, Fernández-Ferreiro A. Almuiña-Varela P, et al. Pharmaceuticals (Basel). 2024 Jan 25;17(2):157. doi: 10.3390/ph17020157. Pharmaceuticals (Basel). 2024. PMID: 38399372 Free PMC article.
A noninterventional study to monitor patients with diabetic macular oedema starting treatment with ranibizumab (POLARIS).
Stefanickova J, Cunha-Vaz J, Ulbig M, Pearce I, Fernández-Vega Sanz A, Theodossiadis P, Kodjikian L, Izmailov A, Muston D, Vassilev Z, Lamotte B, Tückmantel C, Friedl S, Altemark A, Schwarz HJ, Katz T; POLARIS study investigators. Stefanickova J, et al. Acta Ophthalmol. 2018 Dec;96(8):e942-e949. doi: 10.1111/aos.13771. Epub 2018 Apr 25. Acta Ophthalmol. 2018. PMID: 29696809 Free PMC article.
17 results